Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

OQL 011

Next Previous
Drug Profile

OQL 011

Alternative Names: OQL-011

Latest Information Update: 09 Jan 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator OnQuality Pharmaceuticals
  • Class Skin disorder therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Erythrodysaesthesia

Most Recent Events

  • 05 Jan 2023 National Medical Products Administration and Central Drugs Standard Control Organisation approves Part 2 of the NOVA-II phase II clinical trial for OQL 011 in Erythrodysaesthesia
  • 08 Nov 2022 OnQuality Pharmaceuticals initiates enrolment in part 2 of the NOVA-II phase II clinical trial for Erythrodysaesthesia (Hand-Foot Skin Reaction) in USA, China and India (NCT04088318)
  • 08 Nov 2022 OnQuality Pharmaceuticals plans a phase III trial for Erythrodysaesthesia (Hand-Foot Skin Reaction)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top